Autologous graft-versus-host disease after denileukin diftitox and autologous stem cell transplantation for refractory T-cell lymphoma

Leuk Lymphoma. 2009 Jan;50(1):124-6. doi: 10.1080/10428190802517724.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Biopsy
  • Combined Modality Therapy
  • Diphtheria Toxin / therapeutic use*
  • Female
  • Graft vs Host Disease / immunology*
  • Humans
  • Interleukin-2 / therapeutic use*
  • Lymphoma, T-Cell / drug therapy*
  • Lymphoma, T-Cell / immunology
  • Lymphoma, T-Cell / pathology
  • Lymphoma, T-Cell / surgery*
  • Middle Aged
  • Recombinant Fusion Proteins / therapeutic use
  • Stem Cell Transplantation*
  • Transplantation, Autologous / immunology

Substances

  • Antineoplastic Agents
  • Diphtheria Toxin
  • Interleukin-2
  • Recombinant Fusion Proteins
  • denileukin diftitox